Healthtech & Wellness VC Funds

NewDo Venture is a cross-border US-China early-stage venture capital firm founded in 2015 and headquartered in Palo Alto, California, with additional offices in San Mateo and New Haven and team presence in China. The firm explicitly bridges the gap between the United States and Chinese technology markets, backing 'fearless founders' through its angel and growth funds and a hands-on support infrastructure that covers HR, financial management, business process, and legal affairs across both countries. NewDo is led by Managing Partner Jingyuan Wang alongside a team of roughly eight, including six partners, one venture partner, and one principal distributed across the US and China. The firm concentrates on AI, enterprise services, healthcare, cloud computing, SaaS, mobile applications, IoT, computer vision, VR/AR, and education. It primarily writes Series A checks, with investment sizes reported up to approximately $11 million per deal. NewDo has invested in approximately 36 companies, producing 1 unicorn, 2 IPOs, and 5 acquisitions. The standout portfolio name is Rippling, the workforce management platform that NewDo backed at Series A in March 2017 — before the company reached unicorn status in 2020 and a $16.8 billion valuation by May 2025. Other portfolio companies include Lyft, which completed an IPO; BillionToOne, a genetic diagnostics company that was acquired; and ObEN, an AI-powered avatar platform. The most recent disclosed exit was Garten in April 2025. NewDo's cross-border positioning gives it a structural sourcing edge: it can identify exceptional Chinese-origin founders building globally relevant companies and connect US-founded portfolio companies with Chinese enterprise customers, manufacturing partners, and capital markets.

Newfund Capital, founded in 2008, is an entrepreneurial venture capital firm with a strong presence in both Paris and Silicon Valley. With $300 million in assets under management, Newfund focuses on seed-stage startups driving global change. Notable investments include Aircall, Fairmoney, and In2Bones, showcasing their diverse and impactful portfolio. The firm invests primarily in technology, precision medicine, personalized treatment, and brain tech sectors. They emphasize early-stage investments, aiming to support startups from the seed stage through international expansion, particularly in France and North America. Newfund's strategy involves quick decision-making, often providing term sheets within three weeks. They seek entrepreneurs with a global mindset and provide significant value beyond capital, including scaling opportunities, networking, and strategic support. The average check size varies but is tailored to meet the needs of each startup, with Newfund often leading the investment rounds. The team includes key members like Henri Deshays and Patrick Malka, who bring extensive entrepreneurial and investment experience. The team is split between their Paris and Palo Alto offices, allowing them to maintain a strong presence in both Europe and the U.S. For startups looking to scale rapidly with a partner who understands the entrepreneurial journey, Newfund Capital offers a compelling blend of expertise, resources, and strategic guidance.

Newgen Venture Partners is a global angel and seed fund platform founded in 2012 and headquartered in Shanghai, China, with additional offices in Beijing, Hong Kong, and Palo Alto. The firm backs entrepreneurs working in life science and information technology with the most innovative ideas and disruptive technologies, explicitly targeting world-class management and technical teams pursuing disruptive opportunities across TMT, life science, and emerging technology. Newgen is led by Founder and Managing Partner Lu Zhang, who has built the firm into a portfolio of more than 100 companies with accumulated valuations exceeding RMB 50 billion (approximately $7 billion). Newgen leads rounds and is often the first institutional investor in its portfolio companies, writing early seed checks of $100,000 to $3 million. Notable portfolio companies include GrubMarket, a US online grocery and food supply-chain platform that received Newgen's first check at seed in January 2015 and most recently raised a $50 million Series H at a $4.5 billion pre-money valuation in February 2026; HotMaxx, a Chinese food and fast-moving-consumer-goods discount retailer; LePure, a Chinese biotech; and WePie. Portfolio exits include Kheiron Medical Technologies, an AI radiology company acquired by DeepHealth in October 2024, and Paperspace, a cloud GPU infrastructure company. In 2025 to 2026, Newgen led the undisclosed Series A of TuCodec alongside Angel Bay Ventures and MFund. Beyond direct investing, Newgen Capital operates as a limited-partner arm, backing emerging VC funds such as ZPARK Venture and GSR Ventures vehicles, positioning the firm as a platform that accelerates the broader early-stage ecosystem rather than purely deploying direct capital.

Newpath Partners is a Boston-based venture capital firm specializing in life sciences. Founded in 2018 by Dr. Thomas Cahill, Newpath focuses on building biotechnology companies from the ground up, partnering with leading academic scientists to translate groundbreaking scientific discoveries into transformative therapies. With a strong commitment to high-impact ventures, the firm is particularly known for its deep involvement in the early stages of company formation, often acting as a founding investor. Newpath Partners manages multiple funds, with its second fund, raised in 2021, amounting to $350 million. This fund continues Newpath’s mission to back companies with high scientific originality and ambitious goals, particularly in areas like regenerative medicine, genomics, and oncology. The firm typically invests in early-stage ventures, providing not only capital but also strategic guidance and access to a network of industry leaders. Dr. Cahill, who also founded the nonprofit Scientists to Stop COVID-19, leads a team that is highly experienced in both science and business, ensuring that the companies they back are well-positioned to make a significant impact in the life sciences arena. Newpath’s approach is characterized by a close collaboration with founders, aligning interests across scientists, investors, and management teams to drive innovation and success.

Newton Biocapital is a Brussels-based venture capital firm with a strong presence in both Europe and Japan, focusing exclusively on the life sciences sector. Established in 2017, the firm’s investment strategy is centered on supporting companies that tackle chronic diseases, with an emphasis on oncology, metabolic diseases, and neurological conditions. Newton Biocapital plays a hands-on role in its portfolio companies, often leading funding rounds and taking board positions to guide scientific and clinical strategies​. The firm manages two funds—Newton Biocapital I (€114M) and Newton Biocapital II, which is currently targeting €150M. NBC I invested in 14 companies across Europe and Japan, including university spin-offs like Epics Therapeutics and ChromaCure in Belgium, and biotech firms like EditForce in Japan. Newton's approach is deeply integrated with the local ecosystems in both regions, leveraging their strong ties to academic institutions, industry experts, and international investors to facilitate cross-border growth and exits​. Newton’s team combines scientific, regulatory, and investment expertise, led by CEO Alain Parthoens. With offices in Brussels and Tokyo, they are uniquely positioned to bridge the innovation pipeline between Europe and Japan, driving impactful advancements in life sciences​.

NewTribe Capital is a Dubai-based venture capital firm primarily investing in early-stage Web3, blockchain, and AI startups. With a portfolio exceeding 200 projects globally, including sectors like DeFi, gaming, infrastructure, and NFTs, NewTribe actively fosters innovation in the digital space. Some notable investments include Cookie3 and KIP, with an average check size around $200,000. The firm focuses on building long-term partnerships, often providing advisory services such as market-making, growth hacking, and smart contract auditing, to ensure the success of its portfolio companies​. Geographically, NewTribe targets the MENA region, but also extends investments into Europe, Asia, and beyond. Its strategy emphasizes infrastructure development that bridges Web2 and Web3, alongside token-based and equity investments. Notably, NewTribe backs projects aligning with Dubai’s Web3 initiatives, offering support through accelerator programs and partnerships. Led by partners such as Dhaval Parikh and Juliet Su, NewTribe’s team combines technical expertise with deep industry connections. For startups seeking funding, NewTribe looks for founders with strong visions in blockchain or AI, particularly those aiming to create large-scale digital infrastructure.

Nexit Ventures is Finland's oldest and most experienced technology growth capital firm, founded in 1999 and headquartered in Helsinki with a deep presence in Silicon Valley and ecosystem connections into Austin, Texas. The firm describes itself as a Nordic and Transatlantic 'Activist VC' focused on digital transformation, investing primarily in later-stage B2B software and technology companies where its historical success ratio has been close to 80% — well above industry averages. Nexit was co-founded by Artturi Tarjanne, who brings more than 30 years of international IT experience and is one of Finland's pioneering software entrepreneurs, alongside Michel Wendell, Pekka Salonoja, and Risto Siilasmaa — the latter being the former Chairman of Nokia. Current partners also include Sami Karppinen and Risto Yli-Tainio. Nexit manages three fund vehicles totaling roughly EUR 173 million in direct capital, plus a EUR 110.8 million joint operation with 3TS Capital Partners formalised in October 2021: Nexit Infocom 2000 (EUR 66.7 million), Nexit Infocom II (EUR 85 million), and Nexit III (EUR 21.6 million). The firm has made 44 total investments, currently manages 22 active portfolio companies, and has produced 12 exits including acquisitions by Google, Hewlett-Packard, and Nvidia. By geography the portfolio is concentrated in the United States (9 investments) and Finland (6). Notable portfolio companies include Boksi Solutions, which received a Series A follow-on in October 2023; Funambol; Aava Mobile, exited in September 2021; and Aino Health AB, in which Nexit III purchased a 29% stake. Nexit's Activist VC model means the firm takes an unusually engaged role — working directly on strategy, commercial development, and team building alongside portfolio management teams rather than limiting its contribution to board oversight.

Next 10 Ventures, founded in 2018 by former YouTube executive Ben Grubbs, is a venture firm dedicated to the global creator economy. Headquartered in Los Angeles and Singapore, the firm focuses on early-stage investments and incubation of businesses within the digital content space. With a $50 million fund, Next 10 Ventures supports startups that offer tools and services for content creators, such as GoMeta, which helps design interactive experiences, and SuperBam, a digital rights management firm. The firm’s average investments range from $250,000 to $500,000. Next 10 Ventures specializes in creator-driven businesses in areas like education, entertainment, and entrepreneurial ventures. Their investment strategy targets creators looking for long-term growth, avoiding short-term "money-grab" opportunities. The firm also provides substantial operational support, including crafting business models for creators, many of whom lack formal plans. The team, including hires like Lauren Schnipper, formerly of Facebook, is spread across key creative hubs like Los Angeles and Singapore, with plans to scale in regions with high creator activity. The firm looks for creators who fit into categories such as artists, entrepreneurs, and educators, while prioritizing sustainability and community impact​.

Next Coast Ventures, established in 2015 and headquartered in Austin, Texas, focuses on investing in high-growth startups located outside traditional coastal tech hubs. The firm targets early-stage investments, particularly in emerging platforms, enterprise solutions, and consumer-focused businesses. Notable companies in their portfolio include Everly Health, Enboarder, and Diligent Robotics, reflecting their commitment to innovative and transformative technologies. Next Coast Ventures employs a thematic research approach, identifying key investment themes rather than focusing on specific sectors. This allows them to partner with "glass-eating" entrepreneurs—founders who are resilient and driven to build category-defining companies. Their investment strategy is characterized by active involvement, with partners often taking board seats and providing strategic guidance to help portfolio companies scale rapidly. The firm has made 159 investments to date and has successfully exited several companies, including Stoplight and AlertMedia. Founders Michael Smerklo and Thomas Ball lead a team of experienced investors who bring deep industry knowledge and a hands-on approach to their portfolio companies. Startups seeking to partner with Next Coast Ventures should demonstrate strong growth potential and alignment with the firm’s thematic investment focus. The firm’s recent investments, such as in Diligent Robotics and Everly Health, showcase their interest in companies that leverage technology to solve significant problems in healthcare, enterprise software, and consumer markets​.

Next Frontier Capital, founded in 2015 and headquartered in Bozeman, Montana, is an early-stage venture capital firm that partners with mission-driven entrepreneurs in the Rocky Mountain region. The firm focuses on investments in B2B technology and deep tech companies at the Seed and Series A stages. They manage four funds, with the latest being Fund IV, and typically invest between $2 to $10 million per round​. Next Frontier Capital emphasizes supporting the underserved Rocky Mountain startup ecosystem. Their portfolio includes companies like Submittable, Bridger Photonics, and Claravine, reflecting their commitment to high-impact technology ventures​​. The firm values diversity, intellectual rigor, and a strong connection to the region, aiming to create long-lasting companies that contribute significantly to their communities​. The team at Next Frontier Capital, led by founders Will Price and Richard Harjes, brings extensive experience from both venture capital and operational roles. They provide hands-on support to their portfolio companies, leveraging their network and expertise to help founders succeed.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

Next Level Ventures (NLV) is Iowa's largest and most prominent strategic investment firm, founded in 2014 and headquartered in Des Moines. The firm is led by Founder and Managing Partner Craig Ibsen, who brings more than 25 years of operating experience, previously serving as a senior executive at Maytag Corporation and as the founder of Appliancezone, a global appliance-parts supply-chain software company. The team also includes Managing Partner Michael Perrin, Principal Liz Keehner, and long-tenured COO Barbara Gooch, who built operational infrastructure for Churchill Capital and Northstar Capital over 25 years before joining NLV. Across five funds, NLV manages approximately $500 million to $700 million in assets and a portfolio of roughly 45 to 50 companies. Three of those funds target Iowa startups specifically through the Iowa Fund series, while others support broader themes — the Curql Fund, for example, delivers fintech solutions to credit unions nationwide. NLV writes checks from $500,000 to $5 million into companies approaching or at product-market fit raising rounds of $1 million to $4 million, with a strong Midwest bias across agtech, data analytics, fintech, healthtech, IoT, SaaS, and AI. In January 2025 NLV launched Fund III, its fifth vehicle overall and third Iowa-focused fund, with the inaugural investment from that vehicle deployed into Genvax Technologies, an Ames, Iowa biotechnology company, in February 2025. A notable portfolio exit is the acquisition of Tractor Zoom by Anvil App Works. NLV's deep roots in the Iowa entrepreneurial community, combined with its multi-fund scale, position it as both the most active investor and the most connected network in the state's emerging technology ecosystem.

Next Orbit Ventures Fund-I (NOVF) is a Mumbai-based early- and growth-stage venture capital and multi-asset fund manager founded in 2012, led by Founder and Managing Partner Ajay Jalan — a senior dealmaker widely recognised as an architect of India's investment push into semiconductor manufacturing and the broader Electronics System Design and Manufacturing (ESDM) ecosystem. The firm oversees roughly $10 billion of targeted investments across five funds; its Second Fund carried a target corpus of $750 million, and the firm has separately announced a $2 billion capital raise focused on India's semiconductor and electronics industries. The thesis is to position India as the world's preferred ESDM destination, forecasting an $810 billion Indian electronics market. NOVF's most visible initiative is leading the International Semiconductor Consortium (ISMC) in a joint venture with Israel's Tower Semiconductor, which signed a Rs 22,900 crore (approximately $3 billion) MoU to establish a greenfield chip-fabrication plant in Mysuru, Karnataka pending Government of India approval. The fund leads rounds and writes checks spanning from $1 million to more than $50 million across hardware and robotics, deep tech, fintech, healthtech, and consumer electronics. The portfolio comprises roughly 18 companies with seven IPOs and one acquisition. Headline names include Thyrocare Technologies, India's first fully automated diagnostic laboratory, acquired by API Holdings for $613 million in June 2021; RBL Bank, dual-listed on BSE and NSE at approximately $1.25 billion market cap; and Infibeam Avenues. The most recent disclosed exit was Mercator Group in December 2024. NOVF's focus on strategic national infrastructure — semiconductors, electronics manufacturing, and diagnostics — distinguishes it from conventional venture funds and gives it direct access to government policy frameworks and industrial-scale capital deployment.

Next Play Ventures is a venture capital firm founded in 2020 by Jeff Weiner, the former CEO of LinkedIn, with a mission to coach and invest in entrepreneurial leaders building world-class, purpose-driven companies. Weiner is joined by Managing Director Brian Rumao, his former chief of staff. The firm takes a unique approach by blending investment with coaching, helping founders not only grow their businesses but also develop strong leadership skills rooted in compassion and values. The firm’s philosophy centers on the idea that doing well and doing good are not mutually exclusive. Next Play Ventures focuses on early-stage investments, primarily in industries like SaaS, fintech, healthtech, education, and productivity software. Notable portfolio companies include Figma, Brex, Scale, and Common Room. The firm also emphasizes social impact, with a commitment to closing the opportunity gap for underserved communities through initiatives like the Boys & Girls Clubs of the Peninsula and The Compassion Project. The name "Next Play" is inspired by legendary basketball coach Mike Krzyzewski’s philosophy of focusing on the next move, whether in victory or defeat. This reflects Next Play’s commitment to helping founders continually move forward, learning from both successes and failures. By providing a blend of capital and mentorship, Next Play Ventures aims to cultivate resilient, impactful companies and leaders for the long term.

NEXT VENTURES is an early-stage venture capital firm founded in 2019 by seven-time Tour de France winner Lance Armstrong, with offices in Austin, Texas and San Francisco. The firm invests exclusively in companies addressing 'whole person health' — a portfolio spanning sports and fitness, outdoor and endurance, nutrition and wellness, preventive care, and diagnostics. Co-founder Armstrong is joined by General Partner Lionel Conacher, an experienced operator and investor, and Founding Partner Melanie Strong, who focuses on innovative technology investments across health, wellness, and sports. NEXT currently manages roughly $60 million in AUM and has launched a $100 million Fund II to double down on whole-person health, preventive care, and diagnostics. Typical initial checks range from $1 million to $3 million at seed and Series A into revenue-producing, market-validated companies. The portfolio includes 18 companies and has produced 1 unicorn, 3 acquisitions, and several notable portfolio companies. The standout holding is Oura, the smart-ring health-wearable leader that reached unicorn status. Other portfolio names include Humane, an AI wearable company; Genopets, a move-to-earn game; Amp Human, which makes PR Lotion and merged with Momentous; PowerDot, a muscle-recovery technology; Pair Team, a preventive-care platform; Vital BioSciences; and Trial Library. Recent acquisitions include SteadyMD, acquired by DocGo in October 2025, and Hammerhead, acquired by SRAM in January 2022. NEXT VENTURES' sector focus is genuinely differentiated: by concentrating on the intersection of health span, athletic performance, and consumer wellness, the firm accesses a market that most traditional healthcare or consumer VCs approach only partially. The founders' operational networks in endurance sport and fitness provide a sourcing advantage that few funds can replicate.

Next47, the global venture capital arm of Siemens, focuses on investing in early and expansion-stage enterprise tech startups. With a presence in Palo Alto, Berlin, Tel Aviv, London, Munich, and Paris, Next47 specializes in sectors like SaaS, AI, and enterprise technology. Their portfolio boasts notable companies such as Verkada, Skydio, and ChargePoint, reflecting their expertise in backing high-potential tech ventures. Next47's investment strategy emphasizes deep engagement with portfolio companies, providing strategic advice, connections, and resources to help them scale. They lead funding rounds with average check sizes varying based on the stage and requirements of the startup. The firm prides itself on a long-term partnership approach, ensuring consistent support through every growth phase. The fund is highly active, with a robust network of 250+ customers across 15 countries, enabling startups to accelerate their go-to-market strategies and secure significant bookings. Founders benefit from Next47's extensive talent network, assisting in making critical hires and developing executive recruiting strategies. Key team members include Lak Ananth, CEO and Managing Partner, and T.J. Rylander, General Partner, both based in Palo Alto. Their combined experience in venture capital and enterprise tech provides invaluable guidance to startups navigating complex growth trajectories. Next47’s global reach and strategic focus make it a vital player in the enterprise tech venture capital landscape, committed to driving innovation and supporting founders in building the next generation of category-leading companies.

NextGen Venture Partners is a unique venture capital firm that leverages a network-driven approach to investing. Founded in 2012 and based in Baltimore, Maryland, the firm collaborates with over 1,800 Venture Partners to support early-stage and growth-stage companies across various industries in the US​. NextGen typically invests between $1 million to $2 million in seed-stage companies and $3 million to $5 million in growth-stage companies that have $10 million+ in revenue. Their network of Venture Partners, consisting of top entrepreneurs and executives, provides startups with valuable connectivity for sales, hiring, and financing introductions, as well as on-demand advice. The firm's leadership team includes Managing Partners Jon Bassett, Ben Bayat, Brett Gibson, and Chris Keller, along with other experienced professionals like Deborah Chu (Principal) and Corinne Smeriglio (Director of Operations)​. This team brings decades of combined experience in investing and building companies.

NextView Ventures is a venture capital firm specializing in seed-stage investments, focusing on companies that use technology to drive the "Everyday Economy." This includes sectors where people spend significant time, money, and attention. The firm was established in 2011 and operates out of Boston and New York City, with a commitment to backing companies from the concept stage. Notable investments by NextView Ventures include companies such as ThredUp, WHOOP, Attentive, Grove Collaborative, and Skillz. ThredUp, an online fashion resale platform, went public on NASDAQ in 2021. WHOOP, a wearable fitness tracker, has become a significant player in the market, valued at over $3.6 billion. Attentive, an SMS marketing platform, serves over 4,000 e-commerce customers and significantly drives their revenue. NextView Ventures recently closed its fourth fund at $100 million, continuing its high-conviction, hands-on seed strategy. The firm targets the full seed spectrum, from pre-launch and pre-seed companies to those starting to scale, offering initial investments ranging from $400K to $4M​.

NextWave Ventures is a venture capital firm founded in 2010, headquartered in Carlsbad, California. The firm specializes in seed to early-stage investments, focusing on commercializing advanced technologies derived from university-based research across North America. NextWave Ventures targets innovation gaps within large commercial markets, investing in sectors such as artificial intelligence, advanced materials, IoT, 3D bioprinting, and digital media. Their strategy involves forming new companies around university patents, typically making seed investments ranging from $500K to $1.5M, and Series A investments from $1M to $4M, with the ability to participate in larger follow-on rounds through syndicate partnerships. NextWave's approach is distinguished by its active operational involvement, leveraging a low overhead structure and shared resources to mitigate risk. The firm maintains strong strategic relationships with hundreds of university labs across the U.S., which allows it to tap into cutting-edge innovations. The leadership team, composed of experienced investors, entrepreneurs, researchers, and operators, plays a hands-on role in building and scaling the companies within their portfolio. Notable investments include innovative companies like SmartFoam, TRAQ, and Apical Technology, all of which are at the forefront of their respective fields. NextWave's investment philosophy is centered on bridging the gap between academia and commercial markets, ensuring that groundbreaking research translates into viable and impactful businesses​.

Nexus Venture Partners, established in 2006, is a venture capital firm headquartered in Menlo Park, California. The firm focuses on early-stage investments, typically participating in seed and Series A rounds, and is particularly active in the US and India. Nexus has over $2.6 billion in assets under management and invests in sectors such as enterprise software, digital consumer businesses, and technology-driven services. Nexus Venture Partners has an impressive portfolio that includes notable companies like Postman, Delhivery, Druva, and Unacademy. The firm has had significant exits, with companies like Clover Health, Delhivery, and Housing.com achieving substantial growth and market impact. Nexus's investment strategy emphasizes strong partnerships with founders, providing them with extensive support throughout their entrepreneurial journey. The team at Nexus comprises experienced professionals, including co-founders Suvir Sujan, Naren Gupta, and Sandeep Singhal, who bring deep industry expertise and strategic insights to their investments. Nexus Venture Partners continues to be a key player in the venture capital landscape, fostering innovation and scaling successful companies across its target markets​.

NFP Ventures is the strategic venture capital arm of NFP — an Aon company and leading insurance brokerage and benefits consultancy — founded in 2018 and headquartered in New York City. In 2021 NFP became the anchor limited partner of Distributed Ventures, the successor platform that evolved from NFP Ventures and now leads the firm's investment activity. The platform closed a $100 million fund in July 2023 and has grown to approximately $155 million in aggregate commitments. The investment team is led by Shawn Ellis as Founder and General Partner, alongside Partners Adam Blumencranz and Michael Peri. NFP Ventures and Distributed Ventures lead seed and Series A rounds and follow into Series B, writing $1 million to $5 million initial checks into 15 to 20 companies per fund. The firm concentrates on the intersection of health, insurance, and wealth — specifically insurtech, fintech, digital health, HR tech, and employee benefits — where risk, cost, and outcomes converge. A defining advantage is the firm's strategic LP network of insurers and brokerages, which can unlock direct buyer access and commercial pilots for portfolio companies from the first day of partnership. The firm has approximately 33 investments across the platform. Notable portfolio companies include Honeycomb, a reinsurance-backed MGA using AI and computer vision for multi-family property insurance that reached approximately $55 million in total funding by 2024; TrustLayer, a real-time collaborative risk-management and proof-of-insurance verification platform; VaxAtlas, a digital vaccine-management platform; and Harness Wealth, a wealth-management platform. The firm's position inside the NFP and Aon ecosystem gives its portfolio companies an unmatched distribution channel into the corporate insurance and benefits market.

NFX, founded in 2015 and headquartered in San Francisco, is a venture capital firm that specializes in early-stage investments. The firm is renowned for its focus on network effects, which it believes are crucial for building market-transforming companies. NFX invests in a diverse range of sectors, including AI, biotech, fintech, gaming, enterprise software, marketplaces, and crypto, with a particular focus on Silicon Valley and Israel. Notable investments by NFX include companies like DoorDash, Lyft, Patreon, and Houseparty. The firm has made a total of 577 investments and has seen significant exits such as Similarweb and CircleUp. NFX's unique approach involves deeply understanding and leveraging network effects, which it views as essential for startups to compete effectively in today's market​​. The firm was co-founded by James Currier, Pete Flint, Gigi Levy-Weiss, and Stan Chudnovsky, who bring extensive entrepreneurial and investment experience. NFX supports its portfolio companies through The Guild, an active community of over 200 founders who share KPIs, insights, and access to foster mutual growth and success​. NFX aims to transform how true innovators are funded, providing not just capital but also strategic guidance to help startups build sustainable and disruptive businesses​.

NGC Ventures, founded in 2017, is a globally recognized venture capital firm headquartered in Singapore. Specializing in blockchain and Web3 investments, NGC manages over $500 million in assets. The firm has built a diverse portfolio across infrastructure projects, decentralized finance (DeFi), and metaverse applications, supporting early-stage ventures that address critical challenges in the blockchain ecosystem. Notable investments include industry leaders like Solana, Avalanche, Algorand, and Ziliqa, underscoring NGC’s commitment to supporting projects with disruptive potential. The fund takes a hands-on approach, providing startups with more than just capital. NGC leverages its team’s deep expertise in blockchain to offer strategic guidance across market access, product development, regulatory navigation, and token economics. Their global presence extends across Singapore, Shanghai, San Francisco, and beyond, enabling them to support ventures worldwide with a strong emphasis on crypto infrastructure and decentralized computing. NGC Ventures also invests in research and collaborates with academic institutions like the National University of Singapore and UC Berkeley, funding the next generation of Web3 innovations. Backed by prominent players like Huobi Ventures and Babel Finance, NGC continues to scale with initiatives like the $100 million Metaverse Ventures Fund, positioning itself as a leading force in the future of blockchain and decentralized technologies.

ND Capital, formerly known as NanoDimension, is a venture capital firm established in 2002, headquartered in Woodside, California. The firm focuses on investing in disruptive technologies across the life sciences, physical sciences, and data sciences sectors. Their core belief is that significant breakthroughs will arise from the convergence of these scientific disciplines. The firm is led by founder and CEO Aymeric Sallin, who has been pivotal in steering the company towards successful investments. ND Capital supports early to mid-stage companies, particularly those developing innovative and market-disruptive technologies. Their investment strategy targets companies at the forefront of scientific advancements that hold the potential to create substantial impact. ND Capital's diverse portfolio includes investments in companies like Natron Energy, Tarveda Therapeutics, Selecta Biosciences, and SQZ Biotech. The firm has a strong track record with numerous successful exits, such as the acquisition of Serotiny by Johnson & Johnson and Icosavax's IPO. The team at ND Capital consists of experienced professionals with deep expertise in various scientific and industrial fields. This includes Senior Partner Patrick Aebischer, who has extensive experience in biotechnology and academic leadership, and Partner Eric Moessinger, who focuses on life sciences investments. ND Capital's mission is to back visionary founders and innovative startups that push the boundaries of science and technology, driving forward transformative solutions that address global challenges..

Night Ventures, founded in 2021 and based in Austin, Texas, focuses on early-stage investments in consumer, fintech, SaaS, crypto, and health sectors. The firm aims to help startups navigate new forms of customer acquisition and leverage the creator economy and community-driven growth. Notable investments include Marker Learning, a disability healthcare service; Feastables, a gamified snacking brand; and Moonpay, a fiat-to-crypto exchange. Other significant investments are in companies like Groombuggy, which offers mobile pet grooming, and Matador, known for its better energy shots. Night Ventures also has investments in innovative tech companies such as Outtake, which provides content intelligence, and Conduit Commerce, a platform for inventory consolidation. Night Ventures is led by General Partners Reed Duchscher, Ezra Cooperstein, and Ben Mathews, who bring extensive experience in media, entertainment, and technology sectors. The firm emphasizes supporting startups through strategic connections and leveraging its network of influential figures in popular culture to drive consumer engagement and growth.

Nimble Ventures, founded in 2012, is a venture capital firm based in San Francisco, California. The firm focuses on early-stage investments, primarily targeting sectors such as technology, healthcare, biotech, fintech, consumer tech, and blockchain. Nimble Ventures invests globally, with notable investments in companies based in the United States and Israel. Prominent companies in their portfolio include Umbra, a developer of SAR micro-satellites for imagery services, and Terradepth, which provides data collection technology for marine tracking systems. Both companies have shown significant growth and innovation within their respective fields. Nimble Ventures typically invests in Seed and Series A stages, supporting startups with high growth potential and innovative solutions. The firm's investment strategy emphasizes identifying and nurturing early-stage companies that have the potential to transform industries through cutting-edge technology and novel approaches. For startups looking to engage with Nimble Ventures, it is important to demonstrate strong technological capabilities and a clear path to market leadership. The firm values innovative solutions that address substantial market needs and have the potential for significant impact. Key team members include John Burbank, a notable investor with a background in managing substantial venture funds, and Nathan Mee, who brings extensive experience in portfolio management and venture capital investments​.

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.

Nissay Capital, a venture capital firm based in Tokyo and wholly owned by Nippon Life Insurance Company, has a rich history of investments across various stages and sectors. With over 1,200 unlisted companies and 226 IPOs since its inception in 1991, the firm is a significant player in Japan's venture capital landscape. Notable investments include Heartseed, a biotech company, SkyDisc, and LaFabric. They focus on early to growth-stage businesses, with investments ranging from $4M to $740M. Nissay Capital's strategy emphasizes leveraging the vast network of Nippon Life Insurance to support portfolio companies, providing extensive guidance on management strategies and capital policies. They prefer investing in innovative startups that align with their long-term vision of contributing to society, particularly in technology and healthcare sectors. The firm typically co-invests with other major players like Mitsubishi UFJ Capital and CyberAgent Capital, fostering a collaborative investment environment. Key team members include Eiji Arima, the President and CEO, who plays a pivotal role in steering the firm's strategic direction. Nissay Capital prefers entrepreneurs to approach them through well-researched pitches that clearly articulate the market opportunity and technological innovation. Active and involved, they are seen as a hands-on investor committed to the growth and success of their investees

NLC Health Ventures is an Amsterdam-based healthtech venture builder and investment fund founded in 2014 by Bert-Arjan Millenaar, who continues to lead the firm as Founder and CEO. NLC describes itself as the world's largest healthtech venture builder and, since 2023, has been recognized as the most active early-stage healthcare investor in its category. The firm operates across Europe and the United States, co-founding companies from scientific invention through to clinical deployment in biotech, medtech, digital health, and what NLC terms green health. NLC's model is entrepreneurial at scale: each year the firm assesses more than 1,500 scientific inventions submitted by universities, academic hospitals, and corporates across 40-plus countries, then selects 20 to 25 to spin out as new ventures. In 2024 alone NLC launched 20 new companies and secured a record EUR 43.6 million in funding across the portfolio. Across more than a decade the firm has co-founded over 110 ventures — 76 active as of 2024 — impacting more than 2 million patients. The flagship vehicle today is the NLC Health Impact Fund, an Article 9 SFDR-classified fund targeting EUR 100 million with follow-on capacity of up to EUR 9 million per company through Series A and B. Notable portfolio ventures include Nicolab, an AI-driven stroke treatment platform, and Concord Neonatal, a shock-free birth technology originating from Leiden University Medical Centre. NLC is a certified B Corp aligned to UN Sustainable Development Goals 3, 9, and 17. With more than 80 staff — including 40-plus healthcare specialists — the firm provides portfolio companies with regulatory, product development, and clinical trial support. Strategic partnerships include Minnesota MedTech 3.0, announced in February 2025, which connects European startups to the Minnesota medtech corridor.

No Label Ventures (NLV) is a London-based European pre-seed and seed-stage venture capital fund founded in 2022 and publicly launched in March 2023. The fund is led by solo General Partner Ramzi Rafih, whose family fled Lebanon during the civil war. Rafih began his career at J.P. Morgan and spent more than a decade as a late-stage investor at KKR and Silver Lake before transitioning to VC; approximately one-third of NLV's fund is anchored by his former KKR colleagues. NLV focuses exclusively on Europe and is positioned as the first institutional backer specifically for immigrant entrepreneurs, providing first cheques from day one before a lead VC commits. The fund writes tickets of $150,000 to $250,000, with the ability to upscale via LP co-investment. It is sector agnostic across SaaS, developer tools, SMB software, AI, biotech, agtech, climate tech, marketplaces, fintech, and therapeutics. Across nine disclosed investments, portfolio companies include Spore.Bio, which produces FMCG quality-control devices; Callyope, a speech-based remote patient monitoring company that raised a EUR 2.2 million round; Pangea Bio; Zango; Nozomio Labs; and POSTX. Several NLV-backed companies have gone on to raise from Sequoia Capital and other leading European and US firms. NLV's thesis rests on a documented investment inefficiency: immigrant founders in Europe typically raise at 14 percent lower valuations with 24 percent less funding, yet outperform better-capitalised peers by up to 70 percent. By providing unconditional first capital, visa and immigration workflow support, customer introductions, and downstream fundraising guidance, NLV offers a package of support that extends well beyond the cheque itself.

Noaber is a purpose-driven venture fund based in the Netherlands, with a mission to create meaningful and sustainable healthcare solutions. The firm invests in early-stage ventures that drive impactful innovations in healthcare, focusing on improving health outcomes while reducing costs and increasing both patient and provider satisfaction. Noaber’s investment strategy revolves around the “Quadruple Aim” of healthcare, which seeks to improve the overall health of populations, enhance the patient experience, reduce healthcare costs, and improve the work life of healthcare providers. The fund’s core investment areas include health activation, early screening and diagnostics, chronic disease management, and health system innovation. Examples of Noaber’s portfolio include Alba Health, which uses microbiome science and AI to prevent chronic diseases, and Momo Medical, which supports caregivers in nursing homes through advanced patient monitoring technology. Another noteworthy investment is Habitual, a digital intervention program that helps manage type 2 diabetes by providing scalable, cost-effective patient support. Noaber is heavily involved in the (pre-)seed stage and frequently serves as the first professional investor in companies. Although its primary focus is on ventures in the Benelux region, Germany, Austria, Switzerland, and Scandinavia, Noaber is expanding its reach through strategic partnerships, including plans to enter the U.S. market. In addition to direct investments, Noaber also participates in investment funds that share its vision for driving healthcare innovation. Noaber’s approach is hands-on, fostering close collaborations with entrepreneurs to inspire broader investment in socially impactful healthcare innovations.

Noetic Fund is a Toronto-based venture capital firm launched in 2020, specializing in early-stage investments within the healthcare, psychedelic medicine, and biotech sectors. The fund focuses on emerging therapies and technologies aimed at improving mental health, addressing central nervous system disorders, and offering innovative solutions to global healthcare challenges. Noetic is particularly involved in the burgeoning field of psychedelic-based therapeutics, where they support companies working on treatments for conditions such as depression, PTSD, and substance use disorders. With its first fund, Noetic made around 20 investments, including notable companies like COMPASS Pathways, MindMed, and Cybin, all leaders in the psychedelic medicine space. They’ve continued to expand with the launch of Noetic Fund II, aiming to raise $200 million to further invest in groundbreaking therapies. Their strategy includes a long-term focus on companies developing new drug discoveries, digital health solutions, and medical devices that address unmet needs in mental and physical health. Noetic’s leadership includes seasoned venture capitalists and experts in life sciences, positioning the firm to capitalize on the growing acceptance and scientific validation of psychedelic treatments. They collaborate closely with portfolio companies, leveraging their expertise to foster sustainable growth and innovation.

NGP Capital, founded in 2005, is a venture capital firm based in Palo Alto, California. The firm has a significant global presence with offices in Berlin, Helsinki, and Geneva, and focuses on early growth investments in B2B sectors such as cybersecurity, industrial technology, deep tech, robotics, supply chain, and data infrastructure. NGP Capital typically invests $10-15 million in the first round, aiming for a 10-15% ownership stake and an active role in their portfolio companies. The firm manages over $1.6 billion in assets and uses a proprietary AI-powered platform, "Q," to identify and evaluate investment opportunities globally. This system scans and ranks more than 2 million companies, helping NGP make data-driven investment decisions. NGP Capital has invested in more than 100 companies, with notable exits including UC Mobile, acquired by Alibaba for $3.8 billion, and Ganji, acquired by 58.com for $3.6 billion. Other significant portfolio companies include PubMatic, Deliveroo, and Moovit. Their investments are geographically diverse, with 27% in Europe, 38% in the US, and 35% in Asia. The firm continues to leverage its partnership with Nokia, focusing on strategic investments that align with Nokia's innovation framework around 5G and related technologies. This partnership allows NGP Capital to combine financial discipline with technological insights, driving growth and strategic value in their portfolio.

Nomad Ventures is an early-stage VC firm based in Los Angeles, with a strong focus on high-growth, network-effect businesses. Their sector-agnostic approach includes fintech, consumer tech, vertical SaaS, and marketplaces, backing startups that drive new ways for people to earn money online. With notable investments in companies like Cameo and Wheels, Nomad Ventures has a track record of identifying disruptive, scalable business models. The fund primarily targets pre-seed and seed-stage investments, aiming to partner with founders who exhibit grit and a bold vision for the future. They seek startups with operational intensity and scalable distribution advantages. While geographically anchored in the U.S., particularly cities like Los Angeles, New York, Austin, and Miami, they are open to the growing decentralization of startup ecosystems across the country. Led by Chris Taylor, James Mumma, and Marco McCottry—all experienced operators who played key roles at Uber, Bird, and Opendoor—the team brings hands-on expertise and operational guidance to their portfolio companies. They actively co-invest with top-tier VCs like Andreessen Horowitz, often helping lead rounds with average check sizes ranging from $250K to $1M. Nomad is known for being approachable and looking for founders who build defensible businesses with strong marketplace dynamics. Nomad Ventures has raised over $100M and frequently scouts startups through industry relationships and tech scene connections, with a preference for companies demonstrating early, clear traction.

NOMO Ventures is a venture capital firm specializing in early-stage investments in transformative technology companies. With over $100 million in assets under management, NOMO Ventures has a diverse portfolio that includes prominent companies such as Expensify, Nest, MeUndies, Simulate, Better Mortgage, Ponto, Batch, and Railz​ (HealthTech Alpha)​​ (Unicorn Nest)​. Their investment strategy focuses on early-stage ventures, often co-investing with other notable funds like Global Founders Capital and Pioneer Fund. NOMO Ventures tends to back companies that offer innovative solutions and have the potential for significant market impact. They have made investments in a variety of sectors, including health tech, fintech, and consumer products. NOMO Ventures is based in San Francisco and is actively seeking new investments, typically participating in funding rounds ranging from $2 million to $20 million. They have a track record of investing in startups that achieve high growth and profitability. For instance, recent investments include Great Question, a customer research platform, and Pry Financials, which simplifies startup finances​. Key team members include experienced venture investors who provide hands-on support and strategic guidance to their portfolio companies. NOMO Ventures looks for startups with strong, innovative business models and clear market potential. Startups interested in securing investment from NOMO Ventures should prepare a direct and concise pitch that highlights scalability and strategic fit with NOMO's investment focus​.

NOON Ventures is a Copenhagen-based early-stage venture fund, launched in 2020 by Caspar Høgh and Theis Malmborg. The fund focuses on investing in transformative technologies that tackle environmental and climate challenges. With a hands-on approach, NOON Ventures works closely with its portfolio companies, acting as co-developers to support long-term growth. Their sectors of interest include biotech, clean energy, manufacturing, and sustainability, specifically targeting companies in Northern Europe. The fund typically leads or co-leads investments, with check sizes ranging from €2-5 million. Its notable investments include Spectro Inlets, Enduro Genetics, and Lotus Microsystems, all working on innovative solutions in sustainability and tech. NOON Ventures emphasizes its commitment to limiting the number of investments, ensuring they can deeply engage with each startup across strategy, talent acquisition, and customer growth. NOON Ventures has made sustainability central to its mission, and its investments align with this philosophy, aiming to contribute to the UN's Sustainable Development Goals. Entrepreneurs with proven technology and a passion for environmental impact will find an ideal partner in NOON Ventures, especially if they seek more than just financial backing.

NordActif is a venture capital firm with a focus on fostering innovation and growth across various sectors. While specific details about the firm's investments and structure are not widely published, it is clear that NordActif operates within a strategic framework typical of successful VC firms. This includes a focus on diversification, targeting investments across different industries and geographies to minimize risk while maximizing returns. NordActif likely implements a portfolio construction strategy that balances early-stage investments with later-stage opportunities, providing both the capital and operational support needed to help startups scale. The firm would be expected to emphasize key elements such as strong deal sourcing, due diligence, and active portfolio management to drive long-term value creation. Their strategy may also include thematic investing, focusing on sectors with high growth potential, such as technology, healthcare, or sustainability. Additionally, like other venture capital firms, NordActif probably works closely with portfolio companies, offering not just capital but also mentorship and guidance to help them navigate challenges and grow their businesses. In terms of team structure, VC firms typically rely on a combination of experienced partners and a strong network of advisors to identify and support promising investments. NordActif’s approach would likely reflect this, with a focus on creating long-term partnerships with founders and leveraging their expertise to support growth.

NFT Ventures, established in 2014 and based in Stockholm, is a prominent venture capital firm specializing in fintech investments. The firm has carved out a niche within the Nordic fintech ecosystem, backing startups that are transforming the financial industry through innovative technologies. NFT Ventures focuses on a broad range of fintech verticals, including regtech, insurtech, and more, investing in companies that have significant scalability and growth potential. NFT Ventures is an active investor, often taking board seats to provide strategic guidance and operational support to its portfolio companies. The firm has built a diverse portfolio of around 40 companies, including notable names like Gimi, a financial education app for children, and Lunar, a modern digital bank. Their approach extends beyond mere financial investment; they leverage their extensive network and deep industry expertise to help their portfolio companies succeed. With a strong presence in Northern Europe, NFT Ventures is well-positioned to continue driving fintech innovation across the region.

Nordic Makers, established in 2016, is an early-stage investment firm founded by a group of experienced angel investors from the Nordic region. The firm focuses on seed and early-stage investments, primarily in technology-driven startups across the Nordics and Europe. Their investment philosophy centers on providing founder-friendly terms and leveraging their extensive network to support entrepreneurial growth. Notable investments by Nordic Makers include Labster, a leading provider of virtual science labs; Seaborg Technologies, which is developing sustainable nuclear reactor technology; and NextMind, which creates brain-sensing wearable devices for real-time device control. Other significant investments include Willa Pay, Helix Nano, LetsBuild, Singa, and Climateview​. The firm’s founding partners, such as Klaus Nyengaard, Esben Gadsbøll, and Alexander Aghassipour, bring a wealth of experience from successful ventures like Just Eat, WhiteAway, and Zendesk. They focus on fostering cross-border investments and integrating the Nordic and Baltic startup ecosystems.

NordicNinja VC is a leading venture capital fund with a €200 million second fund targeting climate tech and deep tech startups across Northern Europe, the UK, and the Benelux. Founded in 2019, the firm is a joint venture backed by Japan Bank for International Cooperation (JBIC), Honda, Omron, and European investors like BaltCap and Swedbank. NordicNinja invests between €2.5 to €10 million in Series A and B rounds, supporting founders addressing global challenges in sustainability, digitalization, and innovative tech solutions. The fund’s portfolio includes high-profile companies like Bolt, Veriff, Einride, and Voi, emphasizing sectors such as electric and autonomous mobility, AI, and immersive digital tools. While around half of NordicNinja’s investments are concentrated in mobility and transportation due to their potential for significant carbon reduction, the firm has also backed companies in sectors like healthcare and digital identity verification, leveraging AI and mixed reality to solve pressing societal problems. Led by managing partners Shinichi Nikkuni, Marek Kiisa, Rainer Sternfeld, and Tomosaku Sohara, the team combines deep expertise in engineering, green energy, and international business. This allows NordicNinja to bridge Japanese and European ecosystems, offering founders access to Japanese corporate networks, enhancing market reach, and supporting scalable, impactful innovation. The fund prioritizes founders with ambitious visions and a readiness to lead in creating a sustainable, tech-driven future, making NordicNinja an ideal partner for startups ready to tackle the world's most critical challenges.

Noro-Moseley Partners is an Atlanta-based venture capital firm specializing in early growth equity investments, primarily in the healthcare and technology sectors. Established in 1983, the firm targets rapidly scaling companies with significant market disruption potential. Their typical investment size ranges from $5 million to $20 million, focusing on businesses that exhibit over 50% year-over-year growth and strong unit economics. Noro-Moseley Partners has an impressive track record, with exits generating over $4 billion in aggregate enterprise value since 2015. Their portfolio includes companies offering cutting-edge solutions, such as Red Canary, a leader in managed detection and response (MDR) services, and Revenue Analytics, which focuses on revenue management software. Their healthcare investments span various areas like infusion services and healthcare payment integrity platforms. The firm places a strong emphasis on partnering with exceptional management teams, offering not just capital but also strategic support. This hands-on approach is evident through their involvement in helping companies build boards with experienced operators and navigate transitions from service-based to SaaS models. By focusing on high-growth companies with the potential for market disruption, Noro-Moseley Partners continues to be a key player in the venture capital space, particularly in the Southeastern U.S. and beyond.

Norrsken VC is a prominent European venture capital firm focused on impact investing, founded in 2017 in Sweden. The firm supports startups that address significant global challenges while aiming for substantial financial returns. Norrsken VC specializes in sectors such as climate tech, energy, biotech, AI, and health tech, ensuring each investment aligns with the UN Sustainable Development Goals (SDGs)​​. Norrsken VC's portfolio includes high-impact companies like Northvolt, a battery manufacturer; Einride, which develops electric autonomous transport; and 1KOMMA5°, focused on sustainable energy solutions. These companies exemplify Norrsken's commitment to backing startups that positively impact both people and the planet​. The firm recently closed its second fund at €320 million, surpassing its original target of €250 million, making it the largest early-stage generalist impact fund in Europe. This fund is supported by major institutional investors, including Folksam, AP1, and the European Investment Fund (EIF), and aims to empower "force of nature" founders to create impact unicorns​. Norrsken VC's team comprises experienced venture capitalists and industry experts, including General Partners Niklas Adalberth, Tove Larsson, Agate Freimane, and David Frykman. The team is dedicated to finding visionary founders across Europe who share their passion for creating a better future through innovative solutions​.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that provides seed-to-growth financing. The firm focuses on several key sectors, including communications and infrastructure, software, materials, healthcare, and digital media. North Bridge Venture Partners supports companies from their initial stages through to becoming market leaders, leveraging a combination of operational experience and strategic guidance​. The firm has made over 479 investments and has achieved 183 exits. Notable portfolio companies include Couchbase, Markforged, and Lyra Therapeutics. North Bridge has a significant presence in the U.S. market, focusing primarily on early-stage and growth-stage companies operating in healthcare and information technology sectors​. North Bridge is led by a team of experienced professionals, including founder and managing partner Edward Anderson and general partners Richard D'Amore and Jeffrey McCarthy. The firm's strategy emphasizes investing in exceptional entrepreneurs whose ideas have the potential to disrupt their respective industries.

North Coast Ventures (NCV), formerly the North Coast Angel Fund, is a Cleveland, Ohio-based early-stage venture capital firm founded in 2006 by Clay Rankin and Todd Federman, both of whom continue to serve as Managing Directors. NCV is built on an unusual capital structure: more than 400 members — the region's leading investors, entrepreneurs, and operating executives — making it the largest single-chapter investor group in the country. The 64-person team includes 7 partners and a 5-person full-time management staff. Since inception, NCV and its members have deployed over $100 million into nearly 80 Ohio-based companies that today employ more than 2,000 people at average salaries near $100,000. The firm runs two parallel vehicle families focused on B2B SaaS: the North Coast Angel Fund series, now on Angel Fund V and informed by a $5 million state funding allocation with a Seed-through-Series-A mandate; and the North Coast Venture Fund series, with its Acceleration Fund III targeting $50 million anchored by $10 million in state matching, focused on demonstration-stage B2B SaaS. NCV leads rounds and the firm made 4 investments during 2025. Portfolio companies include Remesh, Axuall, Employstream, Proformex, TandemStride, InnerActiv, Vytalize Health, Primum Health — a Columbus oncology platform co-led at seed with FCA Venture Partners — and 1Logtech, an AI-driven logistics company that raised $1.5 million in a Seed round in April 2025. NCV's thesis centers on highly scalable B2B SaaS solving large problems where the member network's domain expertise and relationships with regional Fortune 500 companies can deliver market-making reference customers. The model pairs patient capital with an unusually broad operating network, creating leverage that a conventional two-partner fund cannot match.

North First Ventures (N1V) is an Israeli early-stage venture capital fund founded in 2017 by Founder and Managing Partner Ronen Smooha. The firm is headquartered in the Midtown TLV Office Tower at 144 Menachem Begin Road in Tel Aviv. N1V partners with Israeli seed and Series A stage companies that harness innovative technologies to solve real-world problems within large existing markets or to create entirely new ones. The team draws on a mix of seasoned entrepreneurs, mentors, global business and marketing strategists, and deep technologists who have personally navigated the non-linear journey of building startups across multiple stages and industries. N1V has invested in approximately 12 companies across AI, SaaS, healthcare, cybersecurity, consumer, and commerce. Portfolio highlights include NoTraffic, a real-time traffic management platform using smart sensors to prepare road infrastructure for connected and autonomous vehicles; Cervello, a cybersecurity solution for railways and metro operational networks covering threat detection, asset management, and continuous monitoring; Octopai, an ML-based metadata discovery SaaS platform acquired by Cloudera in 2024; Veego; and Home365. The fund has produced two acquisitions to date — Octopai and Model 9, which was acquired by BMC. The firm's most recent first-time investment was Gaviti, and the most recent follow-on was NoTraffic. N1V positions its involvement as more than financial: the team works hands-on with founders to build business engines that scale, bringing the direct experience of investors who have lived through company-building at multiple stages. The fund is explicit that great technology must be paired with a strong go-to-market and organizational capability to create durable value.

North Shore InnoVentures (NSIV) is a non-profit incubator focused on accelerating the growth of early-stage life sciences and cleantech startups. Based in Beverly, Massachusetts, NSIV provides crucial support through shared lab space, resources, and business mentoring. With two main incubator facilities—the Biotech InnoVenture Center and the Cleantech InnoVenture Center—NSIV has supported over 70 companies since its founding in 2009. Collectively, these startups have raised over $1 billion in funding and created more than 500 jobs​. NSIV specializes in helping companies in the life sciences, healthcare, medical devices, and clean energy sectors. Its investment strategy focuses on early and seed-stag. Led by CEO Chris Ilsley, NSIV emphasizes creating a collaborative environment that nurtures innovation. Companies at NSIV benefit from mentoring programs, expert advisory panels, and connections with potential investors, making it an ideal launching pad for early-stage ventures​.

The North West Fund is a £155 million investment fund aimed at supporting small and medium-sized enterprises (SMEs) in the North West of England. Managed by North West Business Finance Limited, an independent private sector company, the fund was established to address gaps in lending, venture capital, and private equity markets. The fund has been fully invested, supporting over 443 businesses and creating more than 6,300 jobs in the region. The fund comprises several sub-funds, each managed by different fund managers, providing a range of financial support from equity investments to loans. These sub-funds include The North West Fund for Venture Capital, Mezzanine, Loans Plus, Micro Loans, Energy and Environmental, Biomedical, and Digital and Creative. These funds have been instrumental in facilitating the growth and expansion of innovative businesses across various sectors. The North West Fund has a strong team of experienced professionals, including Cliff Maylor (Chief Executive Officer), Neil Morrey (Chief Operating Officer), and Mike Kenyon (Chief Financial Officer). The fund's governance is supported by an independent Board and an Investment Advisory Panel with expertise in private equity, venture capital, and the targeted sectors.

North West Quadrant (NWQ) Ventures, based in Menlo Park, California, is a venture capital firm that specializes in early-stage investments in disruptive technologies. Founded in 2010, NWQ Ventures primarily focuses on companies that are pushing the boundaries of innovation, particularly in sectors like digital media, fintech, and real estate services. NWQ Ventures supports startups that aim to achieve something unprecedented, providing them not just with capital, but also with strategic guidance on patents, manufacturing, market entry, and venture debt financing. The firm has a global outlook and takes a hands-on approach with its portfolio companies, helping them scale through mid-stage growth financing and by leveraging a strong network of co-investors and partners. NWQ's portfolio includes diverse investments like MoonPay and Typewise, showcasing its commitment to high-growth industries. The firm's strategy centers around helping these early-stage companies reach significant milestones by offering both financial and strategic resources. NWQ Ventures operates with a forward-thinking investment thesis, targeting companies that have the potential to reshape their respective industries and create lasting impact. The firm plays a crucial role in bringing new technological advancements to market, ensuring that the startups it backs are well-positioned for success​.

Northern Gritstone is a venture capital firm established in 2020, focused on commercializing cutting-edge science and technology emerging from the North of England. With headquarters in Manchester and strong ties to the Universities of Manchester, Leeds, and Sheffield, Northern Gritstone primarily invests in early-stage companies that originate from these institutions or are based in the region. The firm manages a substantial fund, recently closing at £312 million, to support startups in sectors like deep technology, life sciences, healthcare, and advanced materials. Northern Gritstone's investment strategy is driven by a philosophy of "profit with purpose," aiming to generate financial returns while also contributing to the economic development of the North of England. Northern Gritstone has already made significant investments in companies such as Optalysys, a photonic chip firm, and AssetCool, which develops advanced coatings for industrial applications. The firm is committed to fostering a tech ecosystem in the region, aspiring to create a "Silicon Valley of the North" by backing visionary companies with strong intellectual property and high growth potential.

Northern Light Venture Capital (NLVC) is a US-China cross-border venture capital firm founded in 2005 by Managing Directors Feng Deng, Yan Ke, and Jeffrey Lee. The firm is dual-headquartered in Menlo Park, California with major operating offices in Shanghai and Beijing. Founders Feng Deng and Yan Ke previously co-founded NetScreen Technologies, an enterprise IT-security company that IPO'd on Nasdaq in 2001 and was acquired by Juniper Networks in 2004 for $4.2 billion. NLVC's first fund was anchored by New Enterprise Associates, Greylock Partners, and WebEx co-founder Min Zhu. Today NLVC manages over $4.5 billion across multiple US-dollar and RMB-denominated funds, with its latest flagship being Northern Light Venture Fund V. NLVC leads rounds and invests across seed, Series A, and Series B stages, with a thesis split roughly 70 percent Series A, 20 percent Series B, and 10 percent seed. The investment focus spans TMT, consumer, green tech, and life sciences, with a 'China concept' mandate: companies that leverage China's industrial, economic, or human resources to build lasting global businesses. Across more than 300 portfolio investments, NLVC has produced 13 unicorns, 15 IPOs, and 23 acquisitions. Marquee wins include Meituan, which IPO'd in Hong Kong; Carta, the US cap-table SaaS platform; VIPKid; Aerohive Networks; and Linekong. In 2024 Taimei Technology IPO'd on HKEX at a $937 million market cap, and GenFleet Therapeutics followed in 2025 at $936 million. NLVC operates with deep bench strength across the US-China corridor, enabling portfolio companies to access manufacturing, talent, and distribution resources on both sides of the Pacific. The firm's track record across more than two decades of cross-border investing has made it one of the most consequential China-linked VC firms globally.